Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
With the release of ASCO abstracts, essentially a huge clinical trial data release ahead of the annual cancer conference, we witnessed a few pops and drops among biotech stocks.
In this video, healthcare analyst David Williamson takes a closer look at two stocks seeing 20% moves -- Oncothyreon (NASDAQ: ONTY ) and Halozyme (NASDAQ: HALO ) -- and discusses what these events mean for investors.
Another topic health-care investors need to keep up on is Obamacare, as the law will undoubtedly have far-reaching effects. The Motley Fool's new free report, "Everything You Need to Know About Obamacare," lets you know how your health insurance, your taxes, and your portfolio will be affected. Click here to read more.